MARKET WIRE NEWS
  1. Home
  2. Stock
  3. ABBV
  4. News
ABBV
Quote
Short
News
Articles
Message Board

AbbVie Inc. (NYSE : ABBV ) News

AbbVie Inc. (NYSE: ABBV) News Releases

ABBV News Releases
ABBV : NYSE
SeekingAlpha
MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal
ABBV : NYSE
Baystreet
Cancer Drug Market on Track to Double by 2033: Five Oncology Plays to Watch
ABBV : NYSE
SeekingAlpha
Dividend Roundup: Halliburton, AbbVie, Johnson & Johnson, Delta Air Lines, and more
ABBV : NYSE
SeekingAlpha
Corcept Therapeutics: The Bad News Is Priced In; The Ovarian Cancer Upside Is Not
ABBV : NYSE
SeekingAlpha
AbbVie wins FDA approval for Venclexta-acalabrutinib combo in first-line chronic lymphocytic leukemia
ABBV : NYSE
PR Newswire
U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)
ABBV : NYSE
SeekingAlpha
China drug licensing deals surge nearly 10-fold in value since 2021
ABBV : NYSE
Motley Fool
3 Stocks to Buy and Hold for 2026 and Beyond
ABBV : NYSE
SeekingAlpha
Bristol-Myers Squibb: Oncology Franchise Remains A Core Strength
ABBV : NYSE
SeekingAlpha
AbbVie declares $1.73 dividend
Back to Start

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.